NCORP Pilot Grant Process (2023-2024)
NRG Oncology NCORP committee leaders will host a pilot grant workshop during the NRG Oncology Winter meeting, February 15-17, 2024. An informational session was held on September 11, 2023 and the recording along with slides are now available here:
-Slides
• The request for funding application (RFA) for NCORP pilot projects will be released in Spring 2024. However, anyone interested in applying for this RFA
must submit a Letter of Intent (LOI); due November 3, 2023.
Click here to download the form
• NCORP committee chairs will review LOIs and select those best aligned with committee goals, NCORP priorities and feasible.
• Selected investigators will be notified and invited to attend a workshop at #NRG2024 Winter Meeting in Orlando, Florida; February 15-17, 2024 (date tbd)
NRG NCORP Overview
NRG Oncology received a five-year funding award in fall 2014 to carry out clinical research as a National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Research Base. The NRG NCORP Research Base will provide scientific and statistical leadership for developing, implementing, and analyzing multi-institutional clinical trials of cancer prevention, control, screening, and post treatment surveillance, as well as cancer care delivery research (CCDR).
NRG NCORP research plans are well integrated into NRG Oncology’s scientific program, which includes a unique focus on both women’s health and radiation therapy. The overarching research themes the NRG NCORP plans to pursue include:
- Developing and evaluate interventions designed to prevent or reduce the risk of cancer as well as cancer treatment morbidities, and improve QoL and overall outcomes.
- Testing and further validating patient-reported measures across many cancer disease types to evaluate and design interventions to improve the quality of life of cancer survivors.
- Develop and conduct randomized and pragmatic implementation trials of interventions that have the potential to generate benefits comparable to those found in drug treatment trials.
- Leveraging NRG Oncology’s therapeutic trials to provide a unique research portfolio—with particular foci on women’s cancers and radiation oncology innovation—to NRG Oncology’s research community and across the National Clinical Trials Network (NCTN).
- Understand and address health disparities in an effort to reduce the unequal burden of cancer in the US.
Learn More About Opportunities and Working with NRG NCORP
The First Lady of the United States and NCI Leadership Highlight the Importance of NCORP on World Cancer Day
>>>